Molecular pathogenesis of fibrosis, thrombosis and surfactant dysfunction in the lungs of severe COVID-19 patients

A Krygier, D Szmajda-Krygier, R Świechowski… - Biomolecules, 2022 - mdpi.com
The global scope and scale of the SARS-CoV-2 pandemic led to huge amounts of important
data from clinical observations and experimental analyses being collected, in particular …

A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review

Y Wang, S Chen, S Zheng, Z Zhou, W Zhang… - Arthritis Research & …, 2024 - Springer
Systemic autoimmune rheumatic diseases (SARDs) related pulmonary disease is highly
prevalent, with variable clinical presentation and behavior, and thus is associated with poor …

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease

D Visca, R Centis, E Pontali… - … of Tuberculosis and …, 2023 - ingentaconnect.com
BACKGROUND: The aim of these clinical standards is to provide guidance on 'best
practice'care for the diagnosis, treatment and prevention of post-COVID-19 lung disease …

New Aspects of Lung Transplantation: A Narrative Overview Covering Important Aspects of Perioperative Management

J Fessler, M Finet, M Fischler, M Le Guen - Life, 2022 - mdpi.com
The management of lung transplant patients has continued to evolve in recent years. The
year 2021 was marked by the publication of the International Consensus Recommendations …

Usefulness of KL-6 for predicting clinical outcomes in hospitalized COVID-19 patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - mdpi.com
Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

JM Ruck, EL Bush - Advances in surgery, 2024 - advancessurgery.com
INTRODUCTION The coronavirus disease 2019 (COVID-19) pandemic was a cataclysmic
event that infected over 772 million and killed over 6.9 million people worldwide [1]. The …

[HTML][HTML] Mitigating COVID-19 Mortality and Morbidity in China's Aging Population: A Focus on Available Medications and Future Developments

E Bischof - Aging and Disease, 2023 - ncbi.nlm.nih.gov
The COVID-19 pandemic, often referred to as the geropandemic, has put immense pressure
on global healthcare systems worldwide, leading to a rush in the development and approval …

COVID-19-associated lung fibrosis: Two pathways and two phenotypes, lung transplantation, and antifibrotics

R Hage, MM Schuurmans - Transplantology, 2022 - mdpi.com
COVID-19 can be associated with lung fibrosis. Although lung fibrosis after COVID-19 is a
relatively rare finding, the mere fact that globally a very large number of patients have had …

Fibrose pulmonar pós-COVID-19: uma revisão narrativa

FCC Freitas, ALSFA Dias… - Revista Eletrônica …, 2022 - acervomais.com.br
Objetivo: Abordar e revisar os pontos importantes sobre a ocorrência da fibrose pulmonar
em pacientes pós-COVID-19. Revisão bibliográfica: Recentemente, na pandemia atual de …

Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model

SS Markin, RD Lapshin, OS Baskina… - International Journal of …, 2022 - mdpi.com
Acute lung injury (ALI) as a model of acute respiratory distress syndrome is characterized by
inflammation, complex coagulation, and hematologic abnormalities which result in the …